Put companies on watchlist
AEVIS VICTORIA SA
ISIN: CH0478634105
WKN: A2PLW7
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

AEVIS VICTORIA SA · ISIN: CH0478634105 · EQS - adhoc news (69 News)
Country: Switzerland · Primary market: Switzerland · EQS NID: 2050149
12 December 2024 12:15PM

AEVIS VICTORIA SA – AEVIS VICTORIA announces the acquisition of Spital Zofingen by Swiss Medical Network and a strategic partnership with Kantonsspital Aarau


AEVIS VICTORIA SA / Key word(s): Acquisition
AEVIS VICTORIA SA – AEVIS VICTORIA announces the acquisition of Spital Zofingen by Swiss Medical Network and a strategic partnership with Kantonsspital Aarau

12-Dec-2024 / 12:15 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


Ad hoc announcement pursuant to Art. 53 LR

Fribourg, 12 December 2024

AEVIS VICTORIA SA (AEVS.SW) – AEVIS VICTORIA announces the acquisition of Spital Zofingen by Swiss Medical Network and a strategic partnership with Kantonsspital Aarau

AEVIS VICTORIA SA (AEVIS) announces the acquisition of Spital Zofingen, a subsidiary of Kantonsspital Aarau AG (KSA), by Swiss Medical Network Holding SA (SMN), marking an important milestone in its strategy for growth and the development of integrated healthcare in Switzerland. This acquisition, with payment made in SMN shares, paves the way for a strategic partnership between SMN and KSA.

KSA becomes a strategic shareholder in SMN, holding 3.57% of the capital, thereby establishing a sustainable collaboration between the two institutions. This transaction confirms the valuation of SMN, consistent with the valuation applied during the capital increase with Visana Beteiligungen. 

As a result of this operation, AEVIS’s consolidated equity will increase by CHF 50 million. Additionally, the integration of Spital Zofingen is expected to boost the group’s consolidated revenues by approximately CHF 100 million in 2025, underscoring the significant financial impact of this acquisition. The acquisition of Spital Zofingen will generate substantial synergies, particularly in procurement, training, and resource allocation. These efficiencies are expected to positively impact the group’s consolidated results from the 2025 fiscal year onward, enhancing operational performance and the quality of care. 

This acquisition aligns also with the development of integrated healthcare, a strategic pillar for SMN and KSA. Together, the two partners aim to establish a new collaborative model to benefit patients and enhance the efficiency of the Swiss healthcare system.

Antoine Hubert, Delegate of the Board of AEVIS, said: “This acquisition fits perfectly into our strategy of broadening Swiss Medical Network’s shareholder base by bringing in top-tier strategic partners. By partnering with Kantonsspital Aarau, we strengthen our commitment to integrated healthcare and consolidate our position in the Swiss healthcare market.”

Conference call today at 3 p.m.
AEVIS VICTORIA SA will comment on the transaction in a conference call at 3 p.m. today. The call will be headed by Antoine Hubert, Delegate of the Board. Registration is not required. Dial-in number for participants: +41 43 550 14 52

For further information:
AEVIS VICTORIA SA Media and Investor Relations: c/o Dynamics Group, Zurich
Philippe R. Blangey, prb@dynamicsgroup.ch, +41 (0) 43 268 32 35 or +41 (0) 79 785 46 32
Séverine Van der Schueren, svanderschueren@aevis.com, +41 (0) 79 635 04 10

AEVIS VICTORIA SA - Investing for a better life
AEVIS VICTORIA SA invests in healthcare, hospitality & lifestyle and infrastructure. AEVIS′s main shareholdings are Swiss Medical Network Holding SA (80%, directly and indirectly), the only Swiss private network of hospitals present in the country's three main language regions, MRH Switzerland AG, a luxury hotel group managing eleven luxury hotels in Switzerland and abroad, Infracore SA (30%, directly and indirectly), a real estate company dedicated to healthcare-related infrastructure, Swiss Hotel Properties SA, a hospitality real estate division, and NESCENS SA, a brand dedicated to better aging. AEVIS is listed on the Swiss Reporting Standard of the SIX Swiss Exchange (AEVS.SW). www.aevis.com.



End of Inside Information

2050149  12-Dec-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2050149&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f
Visual performance / price development - AEVIS VICTORIA SA
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.